Mengoc BC 0.5ml Vaccine (Cuba)

The Mengoc BC vaccine is manufactured by Finlay Institute (Cu Ba). The Mengoc BC vaccine is effective against Group B and C Mengoc meningocitis. This vaccine is available for children 6 months and older and adults up to 45 years old.

The Mengoc BC 0.5ml vaccine is manufactured by Finlay Institute (Cu Ba).

The Mengoc BC 0.5ml vaccine is a complex of serum group B pure outer membranes and C serum group polysaccharides of meningococcal bacteria, adsmolytic aluminium hydroxide.

• Vials 1 dose of 0.5 ml. Box containing 10 vials

• Injectable flu mix.

• Mengoc BC 0.5ml vaccine is in place to provide active immunity against meningoctis of serum groups B and C.
• The vaccine is given to subjects aged between full 6 months and 45 years of age and those who live in epidemic areas or must travel to epidemic areas.
• Vaccinations should be given to people living in a community group such as child care centers, boarding schools, military barracks, prisons, high-density areas, or communities that have reported cases of sy serum group meningoc meningocular infections B and C.

Dosage and how to take:

dosage:

• The basic injection schedule consists of 2 doses of 0.5 ml, the distance between injections is 6 to 8 weeks. A second dose of injection is required to achieve a level of protection.
• The injection schedule is applicable to subjects from full 6 months of age to 45 years of age.
• According to the experience of using the vaccine, it is not necessary to repeat the injection after 2 basic doses have been given.
• When conducting repeat injection campaigns, repeat injections do not exclude those who do not have evidence that a previous two-shot scheduled injection has been given.

How to use:

• VA-MENGOC-BC vaccination ® intramuscularly, it is best to vaccinate the delta muscle in accordance with ingested standards.
• In children, the delta muscle area is very small, it is recommended to vaccinate the front of the thigh.
• Since the gel tends to be precipitated, it is necessary to shake the vaccine jar gently before sucking into the injection pump to ensure homomerity.

• Do not give injections to people who are hypersensitive to any component of the vaccine.
• Contraincular in cases of fever, acute infection, progressive allergies and de-compensatory chronic diseases.
• There is rarely a serious reaction that occurs when the first injection occurs, but if any, it is contraining a second injection.

alert:

• After the injection, the injected person needs to wait 30 minutes before carrying out daily activities.
• Appropriate medications (adrenaline solution 1/1000) should be available in case of hypersensitivity reactions.

cautious:

• Keep out of reach of children.
• Read the instructions for use carefully before use.
• Never be vaccinated intravenously.
• Open vials must be preserved from light and at temperatures 2 – 8oC; use only within 24 hours.
• The manufacturer will not be responsible for non-compliance with recommendations for the use and storage of vaccines.
• Do not use expired vaccines.
• Caution should be exercised in patients with tinglet reduction or blood clot disorders as bleeding may occur when intramuscularly injecting these subjects.

• No serious side effects were reported in the majority of those injected in major clinical field reviews and post-licensing studies in CuBa and many other countries.
• Local signs and symptoms known as pain, rash, and stiffness of the injection area are usually mild and have different frequency of appearance, appear within the first 24 hours after injection and tend to disappear after 72 hours after injection. Local reactions to stronger levels may appear in a few single cases. These reactions and signs are similar to those for other apperalic vaccines.
• In body symptoms there are often reports of temperature of 380C or higher and rarely lasting more than 2 days. However, there are rarely reports of a fever of 390C or higher, this symptom occurs quickly.
• There may be unpleasant sensations, headaches and drowsiness.
• Signs and symptoms of body as well as locality usually decrease after the 2nd dose of injection.
• Vaccines do not cause diseases or the main symptoms and signs of the disease.

Pregnant women – Breastfeeding: There has been no research on these subjects. Therefore, It is not recommended to vaccinate Mengoc BC for pregnant or lactated women. Except in cases where it is really necessary to be in an epidemiological area with a high risk of exposure. However, it is necessary to consult a doctor before vaccination.

Shelf Life: 36 months from the date of manufacture.

Special caution when preserving:

• Store in the refrigerator (2°C – 8°C).
• Don't freeze.
• Avoid physical agents such as light, strong radiation.

If you have abnormal symptoms, you should be examined and consulted with a specialist.

Source: According to information approved by the Drug Administration.